ArticleJournal of translational medicine2025
Atomic force microscopy-based topographical imaging of SARS-CoV-2 as part of a tripartite strategy for RNA virus characterization.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe pre-selection of virus particles based on size and morphology is a crucial step toward rapid and reliable virus identification. Pre-selecting virus particles based on size and morphology represents a critical step toward rapid and reliable identification, which is particulary important in clinical settings when novel virus variants emerge. Although conventional fluorescence imaging enables visualization of specific viral structures via labeling, it does not allow for reliable differentiation of structurally similar particles.
methodsIn this study, we present a combined imaging approach that integrates atomic force microscopy (AFM) and double-staining fluorescence microscopy to identify SARS-CoV-2 as a model RNA-virus from other sample constituents.
resultsInitially, topographical imaging via AFM enables high-resolution visualization of individual virus particles, providing detailed information about particle morphology and height. Subsequently, dual fluorescence labeling of the RNA-containing core and the spike protein-rich surface allows for specific identification of intact viral structures. Correlation of fluorescence signals with AFM-derived height maps offers a comprehensive view of the particles’ morphological and molecular characteristics.
conclusionThis triple-correlation strategy enables the identification of intact SARS-CoV-2 particles and their clear distinction from similarly sized hollow particles, viral fragments, and staining artifacts. The height range of confirmed SARS-CoV-2 particles under the applied conditions was determined to be 60–100 nm. The presented correlative imaging approach is broadly applicable to other RNA viruses, offering a versatile tool for high-specificity virus detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.